17alpha-ethynylestradiol affects expression ISO RGD:1313913 6480464 Ethinyl Estradiol affects the expression of HAT1 mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO RGD:1313913 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HAT1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:1313913 6480464 Ethinyl Estradiol results in increased expression of HAT1 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:1313912 6480464 Estradiol inhibits the reaction [sodium arsenite results in increased expression of HAT1 mRNA], sodium arsenite inhibits the reaction [Estradiol results in increased expression of HAT1 mRNA] CTD PMID:22952798 17beta-estradiol increases expression ISO RGD:1313912 6480464 Estradiol results in increased expression of HAT1 mRNA CTD PMID:22952798 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1313912 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1313913 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HAT1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of HAT1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1313913 6480464 Tetrachlorodibenzodioxin affects the expression of HAT1 mRNA CTD PMID:21570461 2,4,6-tribromophenol decreases expression ISO RGD:1313912 6480464 2 more ... CTD PMID:31675489 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of HAT1 mRNA CTD PMID:21346803 2-methylcholine affects expression ISO RGD:1313912 6480464 beta-methylcholine affects the expression of HAT1 mRNA CTD PMID:21179406 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1313912 6480464 tetrabromobisphenol A results in decreased expression of HAT1 protein CTD PMID:31675489 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1313912 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of HAT1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HAT1 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1313912 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of HAT1 mRNA CTD PMID:28628672 4-hydroxyphenyl retinamide increases expression ISO RGD:1313913 6480464 Fenretinide results in increased expression of HAT1 mRNA CTD PMID:28973697 acrylamide increases expression ISO RGD:1313912 6480464 Acrylamide results in increased expression of HAT1 mRNA CTD PMID:32763439 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of HAT1 mRNA CTD PMID:33354967 aflatoxin M1 decreases expression ISO RGD:1313912 6480464 Aflatoxin M1 results in decreased expression of HAT1 mRNA CTD PMID:30928695 all-trans-retinoic acid decreases expression ISO RGD:1313912 6480464 Tretinoin results in decreased expression of HAT1 mRNA CTD PMID:16054129 , PMID:33167477 ammonium chloride increases expression EXP 6480464 Ammonium Chloride results in increased expression of HAT1 protein CTD PMID:16483693 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:1313912 6480464 pyrazolanthrone inhibits the reaction [Quercetin results in increased activity of HAT1 protein] CTD PMID:21165570 aristolochic acid A decreases expression ISO RGD:1313912 6480464 aristolochic acid I results in decreased expression of HAT1 mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO RGD:1313913 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of HAT1 mRNA CTD PMID:23650126 arsane increases methylation ISO RGD:1313912 6480464 Arsenic results in increased methylation of HAT1 promoter CTD PMID:21291286 arsenic atom increases methylation ISO RGD:1313912 6480464 Arsenic results in increased methylation of HAT1 promoter CTD PMID:21291286 arsenite(3-) multiple interactions ISO RGD:1313912 6480464 arsenite promotes the reaction [G3BP1 protein binds to HAT1 mRNA] CTD PMID:32406909 arsenous acid increases expression ISO RGD:1313912 6480464 Arsenic Trioxide results in increased expression of HAT1 protein CTD PMID:25419056 benzatropine multiple interactions ISO RGD:1313912 6480464 [Cuprizone co-treated with Benztropine] results in decreased expression of HAT1 protein CTD PMID:34122009 benzo[a]pyrene multiple interactions ISO RGD:1313913 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of HAT1 mRNA] CTD PMID:22228805 berberine increases expression ISO RGD:1313912 6480464 Berberine results in increased expression of HAT1 mRNA CTD PMID:27311644 bis(2-chloroethyl) sulfide increases expression ISO RGD:1313913 6480464 Mustard Gas results in increased expression of HAT1 mRNA CTD PMID:26392148 bisphenol A increases expression ISO RGD:1313913 6480464 bisphenol A results in increased expression of HAT1 mRNA CTD PMID:26063408 bisphenol A decreases methylation ISO RGD:1313912 6480464 bisphenol A results in decreased methylation of HAT1 gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of HAT1 mRNA CTD PMID:30816183 more ... bisphenol A affects expression ISO RGD:1313912 6480464 bisphenol A affects the expression of HAT1 mRNA CTD PMID:30903817 bisphenol A decreases expression ISO RGD:1313912 6480464 bisphenol A results in decreased expression of HAT1 mRNA, bisphenol A results in decreased expression of HAT1 protein CTD PMID:29275510 , PMID:31675489 bisphenol A increases expression ISO RGD:1313912 6480464 bisphenol A results in increased expression of HAT1 mRNA CTD PMID:28765096 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of HAT1 mRNA CTD PMID:25181051 bisphenol F multiple interactions ISO RGD:1313912 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HAT1 mRNA CTD PMID:28628672 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of HAT1 mRNA CTD PMID:24136188 cannabidiol multiple interactions ISO RGD:1313912 6480464 [Cuprizone co-treated with Cannabidiol] results in decreased expression of HAT1 protein CTD PMID:34122009 captan increases expression ISO RGD:1313913 6480464 Captan results in increased expression of HAT1 mRNA CTD PMID:31558096 carbamazepine affects expression ISO RGD:1313912 6480464 Carbamazepine affects the expression of HAT1 mRNA CTD PMID:24752500 carbon nanotube increases expression ISO RGD:1313913 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1313912 6480464 CGP 52608 promotes the reaction [RORA protein binds to HAT1 gene] CTD PMID:28238834 chalcone decreases activity ISO RGD:1313913 6480464 Chalcone analog results in decreased activity of HAT1 protein CTD PMID:22155221 cisplatin increases expression ISO RGD:1313912 6480464 Cisplatin results in increased expression of HAT1 mRNA CTD PMID:27594783 cisplatin decreases expression ISO RGD:1313913 6480464 Cisplatin results in decreased expression of HAT1 mRNA, Cisplatin results in decreased expression of HAT1 protein CTD PMID:35279909 cisplatin multiple interactions ISO RGD:1313913 6480464 MIR486 mRNA affects the reaction [Cisplatin results in decreased expression of HAT1 protein] CTD PMID:35279909 cisplatin decreases expression ISO RGD:1313912 6480464 Cisplatin results in decreased expression of HAT1 mRNA CTD PMID:27392435 , PMID:35279909 clozapine multiple interactions ISO RGD:1313912 6480464 [Cuprizone co-treated with Clozapine] results in decreased expression of HAT1 protein CTD PMID:34122009 cobalt dichloride decreases expression ISO RGD:1313912 6480464 cobaltous chloride results in decreased expression of HAT1 mRNA CTD PMID:19376846 coumestrol increases expression ISO RGD:1313912 6480464 Coumestrol results in increased expression of HAT1 mRNA CTD PMID:19167446 Cuprizon multiple interactions ISO RGD:1313912 6480464 [Cuprizone co-treated with Benztropine] results in decreased expression of HAT1 protein more ... CTD PMID:34122009 cyclosporin A affects expression ISO RGD:1313912 6480464 Cyclosporine affects the expression of HAT1 mRNA CTD PMID:25562108 decabromodiphenyl ether increases expression ISO RGD:1313912 6480464 decabromobiphenyl ether results in increased expression of HAT1 protein CTD PMID:31675489 dexamethasone multiple interactions ISO RGD:1313912 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of HAT1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HAT1 mRNA CTD PMID:28628672 diarsenic trioxide increases expression ISO RGD:1313912 6480464 Arsenic Trioxide results in increased expression of HAT1 protein CTD PMID:25419056 dibutyl phthalate decreases expression ISO RGD:1313913 6480464 Dibutyl Phthalate results in decreased expression of HAT1 mRNA CTD PMID:17361019 diclofenac affects expression ISO RGD:1313912 6480464 Diclofenac affects the expression of HAT1 mRNA CTD PMID:24752500 dicrotophos decreases expression ISO RGD:1313912 6480464 dicrotophos results in decreased expression of HAT1 mRNA CTD PMID:28302478 enzyme inhibitor multiple interactions ISO RGD:1313912 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of HAT1 protein CTD PMID:23301498 epoxiconazole increases expression ISO RGD:1313913 6480464 epoxiconazole results in increased expression of HAT1 mRNA CTD PMID:35436446 ethanol affects splicing ISO RGD:1313913 6480464 Ethanol affects the splicing of HAT1 mRNA CTD PMID:30319688 fenthion decreases expression ISO RGD:1313913 6480464 Fenthion results in decreased expression of HAT1 mRNA CTD PMID:34813904 fentin chloride increases activity EXP 6480464 triphenyltin chloride results in increased activity of HAT1 protein CTD PMID:15603928 finasteride increases expression EXP 6480464 Finasteride results in increased expression of HAT1 mRNA CTD PMID:24136188 fipronil increases expression EXP 6480464 fipronil results in increased expression of HAT1 mRNA CTD PMID:23962444 flutamide increases expression EXP 6480464 Flutamide results in increased expression of HAT1 mRNA CTD PMID:24136188 folic acid decreases expression ISO RGD:1313913 6480464 Folic Acid results in decreased expression of HAT1 mRNA CTD PMID:25629700 gold atom decreases expression ISO RGD:1313912 6480464 Gold results in decreased expression of HAT1 mRNA CTD PMID:25523186 gold(0) decreases expression ISO RGD:1313912 6480464 Gold results in decreased expression of HAT1 mRNA CTD PMID:25523186 hydrogen peroxide decreases expression ISO RGD:1313912 6480464 Hydrogen Peroxide results in decreased expression of HAT1 mRNA CTD PMID:27655674 indometacin multiple interactions ISO RGD:1313912 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of HAT1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HAT1 mRNA CTD PMID:28628672 ivermectin decreases expression ISO RGD:1313912 6480464 Ivermectin results in decreased expression of HAT1 protein CTD PMID:32959892 L-methionine decreases expression ISO RGD:1313913 6480464 Methionine results in decreased expression of HAT1 mRNA CTD PMID:35314295 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of HAT1 protein CTD PMID:29155171 manganese(II) chloride decreases expression ISO RGD:1313912 6480464 manganese chloride results in decreased expression of HAT1 protein CTD PMID:29155171 N-nitrosodiethylamine increases expression ISO RGD:1313913 6480464 Diethylnitrosamine results in increased expression of HAT1 mRNA CTD PMID:17854601 N-nitrosodiethylamine multiple interactions ISO RGD:1313913 6480464 RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of HAT1 mRNA] CTD PMID:17854601 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of HAT1 mRNA CTD PMID:25729387 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of HAT1 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1313913 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of HAT1 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of HAT1 mRNA CTD PMID:34911549 paracetamol affects expression ISO RGD:1313913 6480464 Acetaminophen affects the expression of HAT1 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:1313912 6480464 Acetaminophen results in increased expression of HAT1 mRNA CTD PMID:22230336 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1313912 6480464 perfluorooctane sulfonic acid results in decreased expression of HAT1 mRNA CTD PMID:27153767 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1313913 6480464 perfluorooctane sulfonic acid results in increased expression of HAT1 protein CTD PMID:26178269 phenobarbital affects expression ISO RGD:1313912 6480464 Phenobarbital affects the expression of HAT1 mRNA CTD PMID:19159669 phenobarbital affects expression ISO RGD:1313913 6480464 Phenobarbital affects the expression of HAT1 mRNA CTD PMID:23091169 picoxystrobin increases expression ISO RGD:1313912 6480464 picoxystrobin results in increased expression of HAT1 mRNA CTD PMID:33512557 pirinixic acid multiple interactions ISO RGD:1313913 6480464 PPARA protein promotes the reaction [pirinixic acid results in increased expression of HAT1 mRNA] CTD PMID:17950772 pirinixic acid increases expression ISO RGD:1313913 6480464 pirinixic acid results in increased expression of HAT1 mRNA CTD PMID:17950772 more ... piroxicam decreases expression ISO RGD:1313912 6480464 Piroxicam results in decreased expression of HAT1 mRNA CTD PMID:21858171 quercetin multiple interactions ISO RGD:1313912 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Quercetin results in increased activity of HAT1 protein], pyrazolanthrone inhibits the reaction [Quercetin results in increased activity of HAT1 protein] CTD PMID:21165570 quercetin increases activity ISO RGD:1313912 6480464 Quercetin results in increased activity of HAT1 protein CTD PMID:21165570 rotenone increases expression ISO RGD:1313912 6480464 Rotenone results in increased expression of HAT1 mRNA CTD PMID:33512557 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of HAT1 protein CTD PMID:35544339 sodium arsenite multiple interactions ISO RGD:1313912 6480464 Estradiol inhibits the reaction [sodium arsenite results in increased expression of HAT1 mRNA], sodium arsenite inhibits the reaction [Estradiol results in increased expression of HAT1 mRNA] CTD PMID:22952798 sodium arsenite increases expression ISO RGD:1313912 6480464 sodium arsenite results in increased expression of HAT1 mRNA CTD PMID:22952798 more ... sodium arsenite increases expression ISO RGD:1313913 6480464 sodium arsenite results in increased expression of HAT1 mRNA CTD PMID:19822182 tamoxifen affects expression ISO RGD:1313913 6480464 Tamoxifen affects the expression of HAT1 mRNA CTD PMID:17555576 tetrachloromethane increases expression ISO RGD:1313913 6480464 Carbon Tetrachloride results in increased expression of HAT1 mRNA CTD PMID:27339419 , PMID:31919559 thimerosal increases expression ISO RGD:1313912 6480464 Thimerosal results in increased expression of HAT1 mRNA CTD PMID:27188386 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of HAT1 mRNA CTD PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of HAT1 mRNA CTD PMID:25729387 trans-chalcone decreases activity ISO RGD:1313913 6480464 Chalcone analog results in decreased activity of HAT1 protein CTD PMID:22155221 tributylstannane increases activity EXP 6480464 tributyltin results in increased activity of HAT1 protein CTD PMID:15603928 trimellitic anhydride increases expression ISO RGD:1313913 6480464 trimellitic anhydride results in increased expression of HAT1 mRNA CTD PMID:19042947 troglitazone decreases expression ISO RGD:1313912 6480464 troglitazone results in decreased expression of HAT1 mRNA CTD PMID:19140230 tungsten increases expression ISO RGD:1313913 6480464 Tungsten results in increased expression of HAT1 mRNA CTD PMID:30912803 valproic acid increases expression ISO RGD:1313912 6480464 Valproic Acid results in increased expression of HAT1 mRNA CTD PMID:23179753 , PMID:29154799 valproic acid affects expression ISO RGD:1313912 6480464 Valproic Acid affects the expression of HAT1 mRNA CTD PMID:25979313 vorinostat increases expression ISO RGD:1313912 6480464 vorinostat results in increased expression of HAT1 mRNA CTD PMID:27188386 zearalenone increases expression ISO RGD:1313912 6480464 Zearalenone results in increased expression of HAT1 mRNA CTD PMID:32119988
